Bacterial competence and genetic diversity: Implications for the design of diagnostics and vaccines.
- 1Department of Medical Laboratory Science, College of Health Sciences, Oda Bultum University, P.O. Box, 226, Chiro, Ethiopia.
Abstract
Bacterial competence and genetic diversity are key determinants of microbial evolution, directly influencing pathogen adaptability, diagnostic reliability, and vaccine effectiveness. Natural transformation, together with horizontal gene transfer and homologous recombination, enables rapid genomic remodeling, facilitating the acquisition of antimicrobial resistance, modification of diagnostic targets, and generation of antigenic variants. These processes are particularly prominent in naturally competent and highly recombining pathogens, where population structures range from clonal to panmictic, shaping responses to selective pressures such as antibiotic use and immunization. This review synthesizes current understanding of the mechanisms governing bacterial competence and their role in generating genomic diversity, with emphasis on implications for diagnostics and vaccine design. Case studies-including Streptococcus pneumoniae, Neisseria meningitidis, and Helicobacter pylori-illustrate how recombination-driven diversification contributes to serotype replacement, diagnostic escape, and variable vaccine performance. Emerging approaches, including pan-genomic target selection, high-throughput sequencing, CRISPR-based diagnostics, and next-generation vaccine platforms, offer strategies to address these challenges but remain constrained by genomic variability and limited global surveillance. We argue that integrating evolutionary dynamics into diagnostic and vaccine development is essential for sustaining effectiveness. Continuous genomic monitoring and adaptive design frameworks will be critical to anticipate and mitigate competence-driven bacterial evolution in clinical and public health settings.
Related
- Sharpness-Aware Minimization (SAM) Improves Classification Accuracy of Bacterial Raman Spectral Data Enabling Portable Diagnostics
- Niche differentiation and functional complementarity between rare and abundant taxa sustain grassland soil bacterial diversity
- Where next for the discipline of nematology? Trends and implications for workforce sustainability, disease diagnostics, and biosecurity
- Dendritic cell diversity and dysfunction in cancer: implications for immunotherapy and therapeutic targeting
- Genetic diversity of endangered Acropora spp. corals in Bonaire: implications for restoration and gene banking
BibTeX
@article{eba2026bacterial,
title = {{Bacterial competence and genetic diversity: Implications for the design of diagnostics and vaccines.}},
author = {Wondimagegn Wolde Eba},
journal = {Biochemistry and biophysics reports},
year = {2026},
month = oct,
doi = {10.1016/j.bbrep.2026.102838},
url = {https://europepmc.org/article/MED/42927278},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Bacterial competence and genetic diversity: Implications for the design of diagnostics and vaccines.
AU - Wondimagegn Wolde Eba
PY - 2026
DA - 2026/10/18
JO - Biochemistry and biophysics reports
DO - 10.1016/j.bbrep.2026.102838
UR - https://europepmc.org/article/MED/42927278
AB - Bacterial competence and genetic diversity are key determinants of microbial evolution, directly influencing pathogen adaptability, diagnostic reliability, and vaccine effectiveness. Natural transformation, together with horizontal gene transfer and homologous recombination, enables rapid genomic remodeling, facilitating the acquisition of antimicrobial resistance, modification of diagnostic targets, and generation of antigenic variants. These processes are particularly prominent in naturally competent and highly recombining pathogens, where population structures range from clonal to panmictic, shaping responses to selective pressures such as antibiotic use and immunization. This review synthesizes current understanding of the mechanisms governing bacterial competence and their role in generating genomic diversity, with emphasis on implications for diagnostics and vaccine design. Case studies-including Streptococcus pneumoniae, Neisseria meningitidis, and Helicobacter pylori-illustrate how recombination-driven diversification contributes to serotype replacement, diagnostic escape, and variable vaccine performance. Emerging approaches, including pan-genomic target selection, high-throughput sequencing, CRISPR-based diagnostics, and next-generation vaccine platforms, offer strategies to address these challenges but remain constrained by genomic variability and limited global surveillance. We argue that integrating evolutionary dynamics into diagnostic and vaccine development is essential for sustaining effectiveness. Continuous genomic monitoring and adaptive design frameworks will be critical to anticipate and mitigate competence-driven bacterial evolution in clinical and public health settings.
SN - 2405-5808
ER -